Longevity LifehacksEvidence Map
Interventions/Alpha-Ketoglutarate (AKG)
Supplement · also: αKG, alpha-ketoglutaric acid, arginine alpha-ketoglutarate (AAKG), ornithine alpha-ketoglutarate

Alpha-Ketoglutarate (AKG)

Krebs-cycle metabolite that drops sharply with age; supplementation extended lifespan and healthspan in mice.

Summary

Alpha-ketoglutarate is made in cells, is used in the Krebs cycle for energy, and is a cofactor for DNA and histone demethylation enzymes; she cites a 10-fold decrease between ages 40 and 80. In mice, supplementation extended lifespan about 10% and compressed late-life frailty, with lower inflammatory cytokines, a reduced senescence inflammatory phenotype, fat browning and preserved ovarian function. Human data are limited: a manufacturer-run trial of AKG plus vitamins, athlete trials with modest effects, and an ongoing placebo-controlled trial (ABLE). A later post notes AKG activated autophagy to stimulate the hair-growth phase.

Debbie's take
Takes a powdered arginine supplement that includes alpha-ketoglutarate, citing its 'many positive benefits for longevity.' From My Current Supplement Stack for Longevity

The evidence

Doses used in studies

Amounts reported in the research, not dosing recommendations.

DoseContext
12 g/day arginine alpha-ketoglutarate, split into 3 dosesMale athletes aged 30-50 (exercise performance, safety)
12 g/day arginine alpha-ketoglutarateMale athletes; little effect on nitric oxide or blood flow

Cautions

  • The FDA considers alpha-ketoglutarate GRAS (generally regarded as safe); she also notes it has several anticancer properties.
  • Arginine plus AKG products may lower blood pressure; check interactions with blood pressure medications, blood thinners, anticoagulants, erectile dysfunction drugs, nitrates and diabetes medications.
  • The supplement level needed to increase healthspan in humans is unknown.

Open questions

Longevity evidence is from mice and worms; human trials are small, industry-run or in young athletes, and the placebo-controlled ABLE trial results are not yet covered.